The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other factors. Healthcare providers often start with one medication but may ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Global Narcolepsy Treatment market to Grow at 5.1% CAGR, Reaching USD 8,718.3 Million by 2034. Key Drivers Include Advanced Drugs, Devices, & Growing Awareness. NEWARK, DE, UNITED STATES ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Lumryz (sodium oxybate) is a prescription drug used to treat excessive daytime sleepiness or cataplexy from narcolepsy. Lumryz can cause side effects that range from mild to serious. Examples ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Narcolepsy. ORLANDO, FLORIDA / ACCESSWIRE / January 9, 2025 / The Assistance Fund, an indep ...